[1] Kishimoto K, Matsumura K, Kataoka Y, et al. Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain[J]. Neuroscience,1999, 92(3):1061-1077

[2] Kanfer JN, Sorrentino G, Sitar DS. Phospholipase as mediators of amyloid beta peptide neurotoxicity: an early event contributing to neurodegeneration characteristic of Alzheimer’s disease[J]. Neurosci Lett, 1998, 257(2):93-96

[3] Dennis EA, Cao J, Hsu YH, et al. Phospholipase A2 enzymes: physical structure, biological function,disease implication, chemical inhibition, and therapeutic intervention[J]. Chem Rev, 2011, 111(10): 6130- 6185

[4] Taketo MM,Sonoshita M. Phospolipase A2 and apoptosis[J].Biochim Biophys Acta,2002,1585(2-3): 72–76

[5] Fenard D, Lambeau G, Valentin E, et al. Secreted phospholipase A2, a new class of HIV inhibitors that block virus entry into host cells[J]. J Clin Invest,1999, 104(5):611-618

[6] Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system[J]. Biochim Biophys Acta, 2006, 1761(11): 1246–1259

[7] Kudo I, Murakmi M. Phospholipase A2 enzymes[J]. Prostaglandins other Lipid Mediat, 2002, 68-69: 3-58

[8] Huggins KW, Boileau AC, Hui DY. Protection against diet-induced obesity and obesity-related insulin resistance in group IB PLA2-deficient mice[J]. Am J Physiol Endocrinol Metab,2002, 283(5):E994-E1001

[9] Labonte ED, Kirby RJ, Schildmeyer NM, et al. Group IB phospholipase A2 mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia[J]. Diabetes, 2006, 55(4): 935-941

[10]Murakami M,TaketomiY, Sato H, et al. Secreted phospholipase A2 revisited[J].J Biochem,2011,150: 233- 255

[11] Chen J, Engle SJ, Seilhamer JJ, et al. Cloning and characterization of novel rat and mouse low molecular weight Ca2+-dependent phospholipases A2 containing 16 cysteines[J]. J Biol Chem,1994,269(37):23018- 23024

[12] Murakami M, Ichiro K. Diversity of phospholipase A2 enzymes[J].Biol Pharm Bull,2004,27(8):1158- 1164

[13]Dillard RD,Bach NJ,Draheim SE, et al.Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides[J]. J Med Chem, 1996, 39(26):5119-5136

[14]Boyanovsky BB,Webb NR.Biology of secretory phospholipase A2[J].Cardiovasc Drugs Ther,2009,23(1): 61-72

[15] Murakami M, Yoshihara K, Shimbara S, et al. Group IID heparin-binding secretory phospholipase A2 is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues[J]. Eur J Biochem, 2002, 269(11): 2698-2707

[16] Li K, Jin JY, Chen WY, et al. Secretory phospholipase A2 group IID is involved in progesterone-induced acrosomal exocytosis of human spermatozoa[J]. J Androl, 2012, 33(5): 975-983

[17] Munoz NM, Meliton AY, Arm JP, et al. Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyper-responsiveness in immune-sensitized mice[J].J Immunol,2007,179(7):4800- 4807

[18] Masuda S, Murakami M, Mitsuishi M, et al. Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells [J]. Biochem J, 2005, 387(Pt1): 27-38

[19] Hanasaki K, Ono T, Saiga A, et al. Purified group X secretory phospholipaseA2 induced prominent release of arachidonic acid from human myeloid leukemia cells[J]. J Biol Chem, 1999, 274(48): 34203-34211

[20]Shridas P,Bailey WM,Boyanovsky BB, et al.Group X secretory phospholipase A2 regulates the expression of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands[J]. J Biol Chem, 2010, 285(26): 20031-20039

[21] Valentin E, Ghomashchi F, Gelb MH, et al. Novel human secreted phospholipase A2 with homology to the group III bee venom enzyme[J]. J Biol Chem, 2000, 275(11): 7492-7496

[22] Sato H, Taketomi Y, Isogai Y, et al. Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice[J]. J Clin Invest, 2010, 120(5): 1400-1414

[23] Masuda S, Yamamoto K, Hirabayashi T, et al. Human group III secreted phospholipase A2 promotes neuronal outgrowth and survival[J]. Biochem J, 2008, 409(2): 429-438

[24] Mounier CM, Wendum D, Greenspan E, et al. Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate[J]. Br J Cancer, 2008, 98(3): 587-595

[25] Gelb MH, Valentin E, Ghomashchi F, et al. Cloning and recombinant expression of a structurally novel human secreted phospholipase A2[J]. J Biol Chem, 2000, 275(51): 39823-39826

[26] Rouault M, Bollinger GJ, Michel L, et al. Novel mammalian group XII screted phospholipase A2 lacking enzymatic activity[J]. Biochemistry, 2003, 42(39): 11494-11503

[27] Murakami M , Taketomi Y, Miki Y, et al. Recent progress in phospholipase A2 research: from cells to animals to humans[J]. Prog Lipid Res, 2011, 50(2): 152-192

[28]谢海峰,李坤,倪崖. 磷脂酶A2亚型及其与男性生殖相关性研究[J].中国细胞生物学学报 (Xie HF, Li K, Ni Y. PLA2 subtypes and their relationships with male reproduction[J].Chin J Cell Biol,2013,35(1):71- 78

[29] Dan P, Rosenblat G, Yedgar S. Phospholipase A2 activities in skin physiology and pathology[J]. Eur J Pharmacol, 2012, 691(1-3):1-8

[30] Murakami M, Taketomi Y, Girard C, et al. Emerging roles of secreted phospholipase A2 enzymes: lessons from transgenic and knockout mice [J]. Biochimie, 2010, 92(6): 561-582

[31] Niessen HW,Krijnen PA,Visser CA, et al.Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes ? [J].Cardiovasc Res,2003,60(1):68- 77

[32] Valentin E, Lambeau G. Increasing molecular diversity of secreted phospholipase A2 and their receptors and binding proteins[J]. Biochim Biophys Acta, 2000, 1488(1-2): 59-70

[33] Bryant KJ, Bidgood MJ, Lei PW, et al. A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism[J]. J Biol Chem, 2011, 286(4): 2492-503

[34] Lee JC, Simonyi A, Sun AY, et al. Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease[J]. J Neurochem, 2011, 116(5): 813-819

[35] Xu S, Chen C, Wang WX, et al. Crucial role of group IIA phospholipase A2 in pancreatitis-associated adrenal injury in acute necrotizing pancreatitis[J]. Pathol Res Pract, 2010, 206(2): 73-82

[36] Xin H, Chen ZY, Lv XB, et al. Serum secretory phospholipase A2-ⅡA levels in pateints surviving acute myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2013, 17(8): 999-1004

[37] Leistad L, Feuerherm AJ, Faxvaag A, et al. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage[J]. Scand J Rheumatol, 2011, 40(4): 308-316

[38] Lambeau G, Gelb MH. Biochemistry and physiology of mammalian secreted phospholipase A2[J]. Annu Rev Biochem, 2008, 77:495-520

[39] Yano T, Fujioka D, Saito Y, et al. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury[J]. Cardiovasc Res, 2011, 90(2): 335-343

[40] Curfs DM, Ghesquiere SA, Vergouwe MN, et al. Macrophage secretory phospholipase A2 group X enhances anti-inflammatory response, promotes lipid accumulation, and contributes to aberrant lung pathology[J]. J Biol Chem, 2008, 283(31):21640-21648

[41] von Allmen CE, Schmitz N, Bauer M, et al. Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells[J]. Proc Natl Acad Sci USA, 2009, 106(28):11673-11678

[42] Scott KF, Sajinovic M, Hein J, et al. Emerging roles for phospholipase A2 enzymes in cancer[J]. Biochimie, 2010, 92(6):601-610

[43] Dong Q, Patel M, Scott KF, et al. Oncogenic action of phospholipase A2 in prostate cancer [J]. Cancer Lett, 2006, 240(1): 9-16

[44] Kupert E, Anderson M, Liu Y, et al. Plasma secretory phospholipase A2-Ⅱa as a potential biomarker for lung cancer in pateints with solitary pulmonary nodules [J]. BMC Cancer, 2011, 11: 513-518

[45] Yu JA, Kalatardi S, Dohse J, et al. Group IIa sPLA2 inhibition attenuates NF-κB activity and promotes apoptosis of lung cancer cells [J]. Anticancer Res, 2012, 32(9):3601-3607

[46] Cai Q, Zhao Z, Antalis C, et al. Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer[J]. FASEB J, 2012, 26(8):3306-3320

[47] Cormier RT, Hong KH, Halberg RB, et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis [J]. Nat Genet, 1997, 17(1), 88-91

[48] Xing XF, Li H, Zhong XY, et al. Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer[J]. Histopathology, 2011, 59(2):198-206

[49] Murakami M, Masuda S, Shimbara S, et al. Cellular distribution, post-translational modification, and tumorigenic potential of human group Ⅲ secreted phospholipaseA2[J]. J Biol Chem, 2005, 280(26): 24987- 24998

[50] Surrel F, Jemel I, Boilard E, et al. Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators[J]. Mol Pharmacol, 2009, 76(4):778-790

[51] Masuda S, Murakami M, Matsumoto S, et al. Localization of various secretory phospholipase A2

   enzymes in male reproductive organs[J]. Biochim Biophys Acta, 2004, 1686(1/2): 61-76

[52] Roldan ER, Shi QX. Sperm phospholipases and acrosomal exocytosis[J]. Front Biosci, 2007, 12: 89-104

[53] Escoffier J, Jemel I, Tanemoto A, et al. Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice[J]. J Clinl Invest, 2010, 120(5): 1415- 1428

[54] Sato H, Kato R, Isogai Y, et al. Analyses of group III secreted phospholipase A2 trans-genic mice reveals potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis[J]. J Biol Chem, 2008, 283(48): 33483-33497

[55] Kimura-Matsumoto M, Ishikawa Y, Komiyama K, et al. Expression of secretory phospholipase A2s

in human atherosclerosis development[J]. Atherosclerosis,2008, 196(1): 81-91

[56] Ivandic B, Castellani LW, Wang XP, et al. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2 [J]. Arterioscler Thromb Vasc Biol, 1999, 19(5): 1284-1290

[57] Bostrom MA,Boyanovsky BB,Jordan CT, et al. Group V secretory phospholipaseA2 promotes atherosclerosis: evidence from genetically altered mice[J]. Arterioscler Thromb Vasc Biol,2007, 27(3): 600-606

[58] Zack M, Boyanovsky BB, Shridas P, et al. Group X secretory phospholipase A2 augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice[J]. Atherosclerosis, 2011, 214(1): 58-64